These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28090302)

  • 1. Three-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertension.
    Shields KJ; Verdelis K; Passineau MJ; Faight EM; Zourelias L; Wu C; Chong R; Benza RL
    Pulm Circ; 2016 Dec; 6(4):586-596. PubMed ID: 28090302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension.
    Faight EM; Verdelis K; Zourelias L; Chong R; Benza RL; Shields KJ
    Pulm Circ; 2017; 7(2):522-530. PubMed ID: 28597764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Pulmonary Arterial Vasoconstriction and Nitric Oxide-Mediated Relaxation Underlie Severe Pulmonary Hypertension in the Sugen-Hypoxia Rat Model.
    Christou H; Hudalla H; Michael Z; Filatava EJ; Li J; Zhu M; Possomato-Vieira JS; Dias-Junior C; Kourembanas S; Khalil RA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):258-274. PubMed ID: 29212831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between endothelial function and micro-vascular remodeling measured by synchrotron radiation pulmonary micro-angiography in pulmonary arterial hypertension.
    Fuji S; Matsushita S; Hyodo K; Osaka M; Sakamoto H; Tanioka K; Miyakawa K; Kubota M; Hiramatsu Y; Tokunaga C
    Gen Thorac Cardiovasc Surg; 2016 Oct; 64(10):597-603. PubMed ID: 27393332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marked Strain-Specific Differences in the SU5416 Rat Model of Severe Pulmonary Arterial Hypertension.
    Jiang B; Deng Y; Suen C; Taha M; Chaudhary KR; Courtman DW; Stewart DJ
    Am J Respir Cell Mol Biol; 2016 Apr; 54(4):461-8. PubMed ID: 26291195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidants for the treatment of patients with severe angioproliferative pulmonary hypertension?
    Voelkel NF; Bogaard HJ; Al Husseini A; Farkas L; Gomez-Arroyo J; Natarajan R
    Antioxid Redox Signal; 2013 May; 18(14):1810-7. PubMed ID: 22870869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.
    Oka M; Homma N; Taraseviciene-Stewart L; Morris KG; Kraskauskas D; Burns N; Voelkel NF; McMurtry IF
    Circ Res; 2007 Mar; 100(6):923-9. PubMed ID: 17332430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Dumas SJ; Bru-Mercier G; Courboulin A; Quatredeniers M; Rücker-Martin C; Antigny F; Nakhleh MK; Ranchoux B; Gouadon E; Vinhas MC; Vocelle M; Raymond N; Dorfmüller P; Fadel E; Perros F; Humbert M; Cohen-Kaminsky S
    Circulation; 2018 May; 137(22):2371-2389. PubMed ID: 29444988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of pirfenidone in the sugen/hypoxia rat model of severe pulmonary hypertension.
    Poble PB; Phan C; Quatremare T; Bordenave J; Thuillet R; Cumont A; Huertas A; Tu L; Dorfmüller P; Humbert M; Ghigna MR; Savale L; Guignabert C
    FASEB J; 2019 Mar; 33(3):3670-3679. PubMed ID: 30481487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of an endothelin receptor antagonist, Macitentan, on right ventricular substrate utilization and function in a Sugen 5416/hypoxia rat model of severe pulmonary arterial hypertension.
    Drozd K; Ahmadi A; Deng Y; Jiang B; Petryk J; Thorn S; Stewart D; Beanlands R; deKemp RA; DaSilva JN; Mielniczuk LM
    J Nucl Cardiol; 2017 Dec; 24(6):1979-1989. PubMed ID: 27688036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sugen-morphine model of pulmonary arterial hypertension.
    Agarwal S; Harter ZJ; Krishnamachary B; Chen L; Nguyen T; Voelkel NF; Dhillon NK
    Pulm Circ; 2020; 10(1):2045894019898376. PubMed ID: 32110385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding longitudinal biventricular structural and functional changes in a pulmonary hypertension Sugen-hypoxia rat model by cardiac magnetic resonance imaging.
    Jayasekera G; Wilson KS; Buist H; Woodward R; Uckan A; Hughes C; Nilsen M; Church AC; Johnson MK; Gallagher L; Mullin J; MacLean MR; Holmes WM; Peacock AJ; Welsh DJ
    Pulm Circ; 2020; 10(1):2045894019897513. PubMed ID: 32095230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension.
    Saito T; Miyagawa K; Chen SY; Tamosiuniene R; Wang L; Sharpe O; Samayoa E; Harada D; Moonen JAJ; Cao A; Chen PI; Hennigs JK; Gu M; Li CG; Leib RD; Li D; Adams CM; Del Rosario PA; Bill M; Haddad F; Montoya JG; Robinson WH; Fantl WJ; Nolan GP; Zamanian RT; Nicolls MR; Chiu CY; Ariza ME; Rabinovitch M
    Circulation; 2017 Nov; 136(20):1920-1935. PubMed ID: 28935667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Src activation reverses pulmonary vascular remodeling in experimental pulmonary arterial hypertension via Akt/mTOR/HIF-1 signaling pathway.
    Liu P; Gu Y; Luo J; Ye P; Zheng Y; Yu W; Chen S
    Exp Cell Res; 2019 Jul; 380(1):36-46. PubMed ID: 30802452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.
    Rafikova O; Williams ER; McBride ML; Zemskova M; Srivastava A; Nair V; Desai AA; Langlais PR; Zemskov E; Simon M; Mandarino LJ; Rafikov R
    Am J Respir Cell Mol Biol; 2018 Sep; 59(3):334-345. PubMed ID: 29652520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.
    Woo E; Kato R; Imano H; Fujiwara Y; Ijiri Y; Okada Y; Yamaguchi T; Izumi Y; Yoshiyama M; Katsumata T; Hayashi T
    Curr Vasc Pharmacol; 2017; 15(6):589-598. PubMed ID: 28460626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual ET
    Nadeau V; Potus F; Boucherat O; Paradis R; Tremblay E; Iglarz M; Paulin R; Bonnet S; Provencher S
    Pulm Circ; 2018; 8(1):2045893217741429. PubMed ID: 29064353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Tongxinluo on pulmonary hypertension and pulmonary vascular remodeling in rats exposed to a low pressure hypoxic environment.
    Wang Y; Ma TT; Gao NN; Zhou XL; Jiang H; Guo R; Jia LN; Chang H; Gao Y; Gao ZM; Pan L
    J Ethnopharmacol; 2016 Dec; 194():668-673. PubMed ID: 27737815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    da Silva Gonçalves Bós D; Van Der Bruggen CEE; Kurakula K; Sun XQ; Casali KR; Casali AG; Rol N; Szulcek R; Dos Remedios C; Guignabert C; Tu L; Dorfmüller P; Humbert M; Wijnker PJM; Kuster DWD; van der Velden J; Goumans MJ; Bogaard HJ; Vonk-Noordegraaf A; de Man FS; Handoko ML
    Circulation; 2018 Feb; 137(9):910-924. PubMed ID: 29167228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
    Li YX; Run L; Shi T; Zhang YJ
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.